ARCHIVES

ODAC Reviews Post-Marketing Studies for Eight Indications

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Recruiting Senior Scientist To Lead AIDS research

May 17, 1996

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

NIH advisors Review Intramural Program, Plan Spring Report

December 10, 1993

NCAB Cancer Centers committee recommends Ratio Cap To Limit Growth of Largest Grants

February 14, 1992

In Brief: NCAB Vacancies Remained Unfilled; AHF’s 20thAnniversary To Be Celebrated In NY May 24

May 5, 1989

In Brief: Benjamin Neel named director of NYU Cancer Center

October 24, 2014